Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Mallinckrodt
Express Scripts
AstraZeneca
Medtronic

Last Updated: June 28, 2022

Drug Price Trends for PEG


✉ Email this page to a colleague

« Back to Dashboard

Drug Price Trends for PEG

Average Pharmacy Cost for PEG

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
PEG-3350 AND ELECTROLYTES SOLN 10572-0101-01 0.00282 ML 2021-06-23
PEG 3350-ELECTROLYTE SOLUTION 10572-0302-01 0.00817 ML 2021-06-23
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G 68682-0201-75 86.57545 EACH 2021-06-23
PEG-3350 AND ELECTROLYTES SOLN 10572-0100-01 0.00282 ML 2021-06-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for PEG

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
COLYTE W/FLAVOR PACKS LIQUID 14 LITRE Mylan Specialty L.P. 00037-6820-04 1X4 54.57 2022-01-15 - 2027-01-14 FSS
COLYTE W/FLAVOR PACKS LIQUID 14 LITRE Mylan Specialty L.P. 00037-6820-04 1X4 21.03 2022-01-15 - 2027-01-14 Big4
EMPAVELI 1080MG/20ML INJ APL Sales I LLC 73606-0010-01 1 3237.60 3237.60000 EACH 2021-12-15 - 2026-12-14 Big4
EMPAVELI 1080MG/20ML INJ APL Sales I LLC 73606-0010-01 1 4260.00 4260.00000 EACH 2021-12-15 - 2026-12-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
McKesson
Mallinckrodt
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.